BIXT News and Press, Bioxytran Inc From 08/12/25

Bioxytran Inc (BIXT) is expected to report for Q2 2025

- ProLectin-M is currently being developed under an active Investigational New Drug (IND) application with the FDA BOSTON, MASSACHUSETTS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company pioneering innova...

- First use of camel hemoglobin as a universal oxygen carrier - Unique properties make it an ideal ingredient for oxygen transport BOSTON, MASSACHUSETTS, June 18, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology c...

Mongolian Gerbil Research Unlocks Critical Insights for Ischemic Stroke and Neurodegenerative Disease Treatments BOSTON, MASSACHUSETTS, June 03, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to t...

PHM23 was one of a handful of molecules chosen by the university Bird Flu helping PHM23 gain awareness of broad-spectrum activity at a university level BOSTON, MASSACHUSETTS, May 21, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage b...

Scor SE ADR (SCRYY) is expected to report $0.07 for Q1 2025 ATA Creativity Global (AACG) is expected to report for Q1 2025 Codere Online Luxembourg S.A. (CDRO) is expected to report $0.05 for Q1 2025 Capital Properties, Inc. - Class A (CPTP) is expected to report for Q1 2025 Sika ...

BOSTON, MASSACHUSETTS, May 12, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing novel antiviral therapies, today announced the successful completion of the dose optimization of its antiviral drug ProLectin-M in...

Stellar Bancorp Inc. (STEL) is expected to report $0.44 for Q1 2025 Aisin Corporation ADR (ASEKY) is expected to report $0.41 for Q4 2025 Saia Inc. (SAIA) is expected to report $2.77 for Q1 2025 Advantest Corporation (ADTTF) is expected to report for Q4 2025 Denso Corporation ADR ...

Oak Valley Bancorp (CA) (OVLY) is expected to report for Q1 2025 reAlpha Tech Corp. (AIRE) is expected to report $-0.04 for Q1 2025 CIB Marine Bancshares Inc (CIBH) is expected to report for Q1 2025 American Overseas Group Ltd (AOREF) is expected to report for quarter end 2024-12-31 ...

- The universal oxygen carrier delivery capabilities of BXT-25 can be monitored, broadening its applications to treat hypoxic diseases - Leading drug candidate ProLectin-M targets galectins in viral infections including bird flu like viruses BOSTON, MASSACHUSETTS, April 11, 2025 (GL...